Angiographic vasospasm versus cerebral infarction as outcome measures after aneurysmal subarachnoid hemorrhage

Acta Neurochirurgica, Supplementum

Volumn 115, Issue , 2013, Pages 33-40

  Etminan, Nima ^a   Vergouwen, Mervyn D I ^b   Macdonald, R Loch ^c,d  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Angiographic vasospasm; Cerebral infarction; Poor outcome; Subarachnoid hemorrhage

Indexed keywords

CENTRAL NERVOUS SYSTEM AGENTS; PLACEBO;

BRAIN ANGIOGRAPHY; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN VASOSPASM; CONFERENCE PAPER; DELAYED CEREBRAL ISCHEMIA; DIGITAL SUBTRACTION ANGIOGRAPHY; GLASGOW OUTCOME SCALE; HUMAN; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANKIN SCALE; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW;

EID: 85052610290     PISSN: 00651419     EISSN: 00016268     Source Type: Book Series    
DOI: 10.1007/978-3-7091-1192-5_8     Document Type: Conference Paper

References (42)

1. Asano T, Takakura K, Sano K, Kikuchi H, Nagai H, Saito I, Tamura A, Ochiai C, Sasaki T (1996) Effects of a hydroxyl radical scavenger on delayed ischemic neurological de fi cits following aneurysmal subarachnoid hemorrhage: Results of a multicenter, placebo-controlled double-blind trial. J Neurosurg 84:792-8033
2. Chou SH, Smith EE, Badjatia N, Nogueira RG, Sims JR 2nd, Ogilvy CS, Rordorf GA, Ayata C (2008) A randomized, doubleblind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage. Stroke 39:2891-28933
3. Dreier JP, Korner K, Ebert N, Gorner A, Rubin I, Back T, Lindauer U, Wolf T, Villringer A, Einhaupl KM, Lauritzen M, Dirnagl U (1998) Nitric oxide scavenging by hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K + is increased in the subarachnoid space. J Cereb Blood Flow Metab 18:978-9900
4. Etminan N, Vergouwen MD, Ilodigwe D, Macdonald RL (2011) Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis. J Cereb Blood Flow Metab 31:1443-14511
5. Findlay JM, Kassell NF, Weir BK, Haley EC Jr, Kongable G, Germanson T, Truskowski L, Alves WM, Holness RO, Knuckey NW et al (1995) A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 37:168-176, discussion 177-1688
6. Gomis P, Graftieaux JP, Sercombe R, Hettler D, Scherpereel B, Rousseaux P (2010) Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage. J Neurosurg 112:681-6888
7. Haley EC Jr, Kassell NF, Torner JC (1993) A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study. J Neurosurg 78:537-5477
8. Haley EC Jr, Kassell NF, Torner JC (1993) A randomized trial of nicardipine in subarachnoid hemorrhage: Angiographic and transcranial Doppler ultrasound results. A report of the cooperative aneurysm study. J Neurosurg 78:548-5533
9. Haley EC Jr, Kassell NF, Apperson-Hansen C, Maile MH, Alves WM (1997) A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in North America. J Neurosurg 86:467-4744
10. Hop JW, Rinkel GJ, Algra A, Berkelbach van der Sprenkel JW, van Gijn J (2000) Randomized pilot trial of postoperative aspirin in subarachnoid hemorrhage. Neurology 54:872-8788
11. Kassell NF, Haley EC Jr, Apperson-Hansen C, Alves WM (1996) Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in Europe, Australia, and New Zealand. J Neurosurg 84:221-2288
12. Kreiter KT, Mayer SA, Howard G, Knappertz V, Ilodigwe D, Sloan MA, Macdonald RL (2009) Sample size estimates for clinical trials of vasospasm in subarachnoid hemorrhage. Stroke 40:2362-23677
13. Lanzino G, Kassell NF (1999) Double-blind, randomized, vehiclecontrolled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America. J Neurosurg 90:1018-10244
14. Lanzino G, Kassell NF, Dorsch NW, Pasqualin A, Brandt L, Schmiedek P, Truskowski LL, Alves WM (1999) Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa. J Neurosurg 90:1011-10177
15. Lovelock CE, Rinkel GJ, Rothwell PM (2010) Time trends in outcome of subarachnoid hemorrhage: Population-based study and systematic review. Neurology 74:1494-15011
16. Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, Frey A, Roux S, Pasqualin A (2008) Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): Randomized, double-blind, placebo-controlled phase 2 dose- fi nding trial. Stroke 39:3015-30211
17. Mayer SA, Kreiter KT, Copeland D, Bernardini GL, Bates JE, Peery S, Claassen J, Du YE, Connolly ES Jr (2002) Global and domain-speci fi c cognitive impairment and outcome after subarachnoid hemorrhage. Neurology 59:1750-17588
18. Neil-Dwyer G, Mee E, Dorrance D, Lowe D (1987) Early intervention with nimodipine in subarachnoid haemorrhage. Eur Heart J 8(Suppl K):41-477
19. Ohman J, Heiskanen O (1988) Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg 69:683-6866
20. Ono H, Mizukami M, Kitamura K, Kikuchi H (1984) Ticlopidine: quo vadis? Subarachnoid hemorrhage. Agents Actions Suppl 15:259-2722
21. Petruk KC, West M, Mohr G, Weir BK, Benoit BG, Gentili F, Disney LB, Khan MI, Grace M, Holness RO et al (1988) Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 68:505-5177
22. Philippon J, Grob R, Dagreou F, Guggiari M, Rivierez M, Viars P (1986) Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine. Acta Neurochir (Wien) 82:110-1144
23. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, Humphrey PR, Lang DA, Nelson R, Richards P et al (1989) Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 298:636-6422
24. Saito I, Asano T, Sano K, Takakura K, Abe H, Yoshimoto T, Kikuchi H, Ohta T, Ishibashi S (1998) Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological de fi cits after aneurysmal subarachnoid hemorrhage. Neurosurgery 42:269-277, discussion 277-2688
25. Shaw MD, Vermeulen M, Murray GD, Pickard JD, Bell BA, Teasdale GM (2000) Ef fi cacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: A report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group. J Neurosurg 93:992-9977
26. Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K, Nagata I, Kikuchi H, Takemae T, Hidaka H et al (1992) Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled doubleblind trial. J Neurosurg 76:571-5777
27. Siironen J, Juvela S, Varis J, Porras M, Poussa K, Ilveskero S, Hernesniemi J, Lassila R (2003) No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: A randomized, double-blind, placebo-controlled clinical trial. J Neurosurg 99:953-9599
28. Springborg JB, Moller C, Gideon P, Jorgensen OS, Juhler M, Olsen NV (2007) Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: A double blind randomised clinical trial. Acta Neurochir (Wien) 149:1089-1101, discussion 11011
29. Suzuki S, Sano K, Handa H, Asano T, Tamura A, Yonekawa Y, Ono H, Tachibana N, Hanaoka K (1989) Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasms and delayed cerebral ischaemic symptoms after subarachnoid haemorrhage due to aneurysmal rupture: A randomized double-blind study. Neurol Res 11:79-888
30. Treggiari MM, Deem S (2009) Which H is the most important in triple-H therapy for cerebral vasospasm? Curr Opin Crit Care 15:83-866
31. Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ (2005) Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic de fi cits after aneurysmal subarachnoid hemorrhage: A phase II randomized placebo-controlled trial. Stroke 36:1627-16322
32. Tseng MY, Hutchinson PJ, Richards HK, Czosnyka M, Pickard JD, Erber WN, Brown S, Kirkpatrick PJ (2009) Acute systemic erythropoietin therapy to reduce delayed ischemic de fi cits following aneurysmal subarachnoid hemorrhage: A phase II randomized, double-blind, placebo-controlled trial. Clinical article. J Neurosurg 111:171-1800
33. van den Bergh WM, Algra A, van Kooten F, Dirven CM, van Gijn J, Vermeulen M, Rinkel GJ (2005) Magnesium sulfate in aneurysmal subarachnoid hemorrhage: A randomized controlled trial. Stroke 36:1011-10155
34. van den Bergh WM, Algra A, Dorhout Mees SM, van Kooten F, Dirven CM, van Gijn J, Vermeulen M, Rinkel GJ (2006) Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH study. Stroke 37:2326-23300
35. Vergouwen MD, Vermeulen M, de Haan RJ, Levi M, Roos YB (2007) Dihydropyridine calcium antagonists increase fi brinolytic activity: A systematic review. J Cereb Blood Flow Metab 27:1293-13088
36. Vergouwen MD, Vermeulen M, Coert BA, Stroes ES, Roos YB (2008) Microthrombosis after aneurysmal subarachnoid hemorrhage: An additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab 28:1761-17700
37. Vergouwen MD, Meijers JC, Geskus RB, Coert BA, Horn J, Stroes ES, van der Poll T, Vermeulen M, Roos YB (2009) Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: A double-blind, placebo-controlled randomized trial. J Cereb Blood Flow Metab 29: 1444-14533
38. Vergouwen M, Vermeulen M, van Gijn J, Rinkel G, Wijdicks E, Muizelaar J, Mendelow A, Juvela S, Yonas H, Terbrugge K, Macdonald R, Diringer M, Broderick J, Dreier J, Roos Y (2010) De fi nition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies - proposal of a multidisciplinary research group. Stroke 41:2391-23955
39. Vergouwen MD, Etminan N, Ilodigwe D, Macdonald RL (2011) Lower incidence of cerebral infarction correlates with improved functional outcome after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab 31:1545-15533
40. Vergouwen M, Ilodigwe D, Macdonald R (2011) Cerebral infarction after aneurysmal subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke 42:924-9299
41. Westermaier T, Stetter C, Vince GH, Pham M, Tejon JP, Eriskat J, Kunze E, Matthies C, Ernestus RI, Solymosi L, Roosen K (2010) Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: A randomized, placebocontrolled, clinical study. Crit Care Med 38:1284-12900
42. Wong GK, Poon WS, Chan MT, Boet R, Gin T, Ng SC, Zee BC (2010) Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): A randomized, double-blinded, placebo- controlled, multicenter phase III trial. Stroke 41:921-9266